During the past decade, Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital" are "Hemophilia A" (2 trials), "Cardiovascular Disease" (1 trials), "Haemophilia" (1 trials), "Hemophilia B" (1 trials) and "Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor" (1 trials). Many other conditions were trialed in "Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital" in a lesser frequency.

Most popular intervention types in "Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (2 trials), "BAX 326 (Recombinant factor IX)" (1 trials), "Factor VIII (FVIII)" (1 trials) and "Optivate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".